Leone, G., Wong, Y. N. S., Jones, R. J., Sankey, P., Josephs, D. H., Crabb, S. J., Harris, L., Zarkar, A., Protheroe, A., Vasudev, N., Rashid, M., Lopes, A., Tasnim, A., Ensell, L., Hartley, J., Jayaram, A., Kularatne, B., Kayani, M., Pritchard, C. C., Konnick, E. Q., Freeman, A., Haider, A., Linares, J., Attard, G., Quezada, S. A., Swanton, C., Marafioti, T., Linch, M. D. (2025). Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02637